Nordson 10-Q 2026-01-31
Filed 2026-02-19. 7 sections, 121K characters. Original on sec.gov · Markdown · JSON
Cover and table of contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
| ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended January 31, 2026
OR
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number 0-7977
____________________________________________________
NORDSON CORPORATION
(Exact name of registrant as specified in its charter)
___________________________________________________
Ohio
(State or other jurisdiction of incorporation or organization)
28601 Clemens Road
Westlake, Ohio
(Address of principal executive offices)
34-0590250
(I.R.S. Employer Identification No.)
44145
(Zip Code)
(440) 892-1580
(Registrant's Telephone Number, Including Area Code)
Securities registered pursuant to Section 12(b) of the Act:
| Title of Each Class | Trading Symbol(s) | Name of Each Exchange On Which Registered | ||||||||||||
| Common Shares, without par value | NDSN | Nasdaq Stock Market LLC |
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes x No o
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☒ | Accelerated filer | ☐ | |||||||||||
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ | |||||||||||
| Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No x
Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date: Common Shares, without par value as of February 18, 2026: 55,783,598
Table of Contents
Page 2
Nordson Corporation
Part I – FINANCIAL INFORMATION
| ITEM 1. | FINANCIAL STATEMENTS (UNAUDITED) |
Condensed Consolidated Statements of Income
| Three Months Ended | ||||||||||||||||||||||||||
| (In thousands, except for per share data) | January 31, 2026 | January 31, 2025 | ||||||||||||||||||||||||
| Sales | $ | 669,461 | $ | 615,420 | ||||||||||||||||||||||
| Cost of sales | 303,339 | 279,524 | ||||||||||||||||||||||||
| Selling and administrative expenses | 199,717 | 194,949 |
Showing the first 8K of 88K characters. Open the full section
Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following is management's discussion and analysis of certain significant factors affecting our financial condition and results of operations for the periods included in the accompanying condensed consolidated financial statements. Throughout this Quarterly Report on Form 10-Q, components may not sum to totals due to rounding.
Overview
Nordson is an innovative precision technology company that leverages a scalable growth framework expected to deliver top tier growth with leading margins and returns. We engineer, manufacture and market differentiated products and systems used for precision dispensing, applying and controlling of adhesives, coatings, polymers, sealants, biomaterials, and other fluids, to test and inspect for quality, and to treat and cure surfaces and various medical products such as: catheters, cannulas, medical balloons and medical tubing. These products are supported with extensive application expertise and direct global sales and service. We serve a wide variety of consumer non-durable, consumer durable and technology end markets including packaging, electronics, medical, appliances, energy, transportation, precision agriculture, building and construction, and general product assembly and finishing.
Our strategy for long-term growth is based on solving customers’ needs globally. We were incorporated in the State of Ohio in 1954 and are headquartered in Westlake, Ohio. Our products are marketed through a network of direct operations in more than 35 countries.
As of January 31, 2026, we had approximately 8,200 employees worldwide. We have principal manufacturing operations and sources of supply in the United States, the People’s Republic of China, Germany, Ireland, India, Israel, Italy, Mexico, the Netherlands and the United Kingdom.
Critical Accounting Policies and Estimates
A comprehensive discussion of the Company’s critical accounting policies and management estimates and significant accounting policies followed in the preparation of the financial statements is included in Item 7 of our Annual Report on Form 10-K for the year ended October 31, 2025 (the "2025 Form 10-K"). There have been no significant changes in critical accounting policies, management estimates or accounting policies followed since the year ended October 31, 2025.
Results of Operations
Below is a detailed comparison of our results of operations for the three months ended January 31, 2026 and January 31, 2025.
As used throughout this Quarterly Report on Form 10-Q, geographic regions include the Americas (United States, Canada, Mexico and Central and South America), Asia Pacific and Europe.
Consolidated Financial Results
Consolidated financial results for the three months ended January 31, 2026 and January 31, 2025 were as follows:
| Three Months Ended | ||||||||||||||||||||
| (In thousands except for per-share amounts) | January 31, 2026 | January 31, 2025 | Change | |||||||||||||||||
| Sales | $ | 669,461 | $ | 615,420 | 8.8 | % | ||||||||||||||
| Cost of sales | 303,339 | 279,524 | 8.5 | % | ||||||||||||||||
| Gross margin | 366,122 | 335,896 | 9.0 | % | ||||||||||||||||
| Gross margin % | 54.7 | % | 54.6 | % | 0.1 | % | ||||||||||||||
| Selling and administrative expenses | 199,717 | 194,949 | 2.4 | % | ||||||||||||||||
| Operating profit | 166,405 | 140,947 | 18.1 | % | ||||||||||||||||
| Interest expense - net | (22,741) | (25,618) | (11.2) | % | ||||||||||||||||
| Other income - net | 20,837 | 1,526 | 1265.5 | % | ||||||||||||||||
| Income before income taxes | 164,501 | 116,855 | 40.8 | % | ||||||||||||||||
| Income tax expense | 31,119 | 22,203 | 40.2 | % | ||||||||||||||||
| Net income | $ | 133,382 | $ | 94,652 | 40.9 | % |
Page 19
Nordson Corporation
Net Sales
Net sales for the IPS, MFS and ATS segments were as follows:
| Three Months Ended | Variance - Increase (Decrease) | ||||||||||||||||||||||||||||||||||||||||
| Jan 31, 2026 | % of Total | Jan 31, 2025 | % of Total | Organic | Acquisitions / Divestitures | Currency | Total | ||||||||||||||||||||||||||||||||||
| IPS | $ | 326,861 | 48.8% | $ | 300,448 | 48.8% | 3.2 | % | — | % | 5.6 | % | 8.8 | % | |||||||||||||||||||||||||||
| MFS | 193,183 | 28.9% | 193,609 | 31.5% | 2.7 | % | (4.3) | % | 1.4 | % | (0.2) | % | |||||||||||||||||||||||||||||
| ATS | 149,417 | 22.3% | 121,363 | 19.7% | 20.7 | % | — | % | 2.4 | % | 23.1 | % | |||||||||||||||||||||||||||||
| Total | $ | 669,461 | $ | 615,420 | 6.5 | % | (1.4) | % | 3.7 | % | 8.8 | % | |||||||||||||||||||||||||||||
The IPS organic sales increase of 3.2 percent was driven by balanced growth across most product lines, with particular strength in Asia Pacific markets. MFS organic sales increased 2.7 percent driven by growth in fluid solutions product lines. The ATS organic sales increase of 20.7 percent was driven by ongoing growth in electronics dispense and recovering demand for x-ray systems.
Net Sales by region were as follows:
| Three Months Ended | Variance - Increase (Decrease) | |||||||||||||||||||||||||||||||||||||
| Jan 31, 2026 | % of Total | Jan 31, 2025 | % of Total | Organic | Acquisitions / Divestitures | Currency | Total | |||||||||||||||||||||||||||||||
| Americas | $ | 261,930 | 39.1% | $ | 267,836 | 43.5% | (0.4) | % | (2.9) | % | 1.1 | % | (2.2) | % | ||||||||||||||||||||||||
| Europe | 182,461 | 27.3% | 167,762 | 27.3% | (0.3) | % | (0.2) | % | 9.3 | % | 8.8 | % | ||||||||||||||||||||||||||
| Asia Pacific | 225,070 | 33.6% | 179,822 | 29.2% | 23.2 | % | — | % | 2.0 | % | 25.2 | % | ||||||||||||||||||||||||||
| Total | $ | 669,461 | $ | 615,420 | 6.5 | % | (1.4) | % | 3.7 | % | 8.8 | % | ||||||||||||||||||||||||||
Gross profit and Selling and administrative expenses
Gross margins were 54.7 percent and 54.6 percent for the three months ended January 31, 2026 and January 31, 2025, respectively. Selling and administrative expenses increased in support of higher sales but declined as a percentage of sales.
Profit
Segment EBITDA for the IPS, MFS and ATS segments and a reconciliation to consolidated operating profit were as follows for the three months ended January 31, 2026 and January 31, 2025, respectively:
| Three Months Ended | ||||||||||||||||||||||||||||||||||||||||||||
| Jan 31, 2026 | % of Sales | Jan 31, 2025 | % of Sales | % of Sales Change | ||||||||||||||||||||||||||||||||||||||||
| Industrial precision solutions | $ | 110,311 | 33.7% | $ | 112,776 | 37.5% | (3.8)% | |||||||||||||||||||||||||||||||||||||
| Medical and fluid solutions | 70,206 | 36.3% | 64,332 | 33.2% | 3.1% | |||||||||||||||||||||||||||||||||||||||
| Advanced technology solutions | 32,600 | 21.8% | 22,771 | 18.8% | 3.0% | |||||||||||||||||||||||||||||||||||||||
| Total segment EBITDA | 213,117 | 31.8% | 199,879 | 32.5% | (0.7)% | |||||||||||||||||||||||||||||||||||||||
| Inventory step-up amortization | — | (3,135) | ||||||||||||||||||||||||||||||||||||||||||
| Acquisition costs | — | (1,030) | ||||||||||||||||||||||||||||||||||||||||||
| Severance and other | — | (5,961) | ||||||||||||||||||||||||||||||||||||||||||
| Depreciation and amortization | (36,585) | (37,030) | ||||||||||||||||||||||||||||||||||||||||||
| Corporate expenses | (10,127) | (11,776) | ||||||||||||||||||||||||||||||||||||||||||
| Operating profit | $ | 166,405 | $ | 140,947 | ||||||||||||||||||||||||||||||||||||||||
Segment EBITDA for IPS decreased 380 basis points despite higher sales due to unfavorable product and geographic mix. Segment EBITDA for MFS increased 310 basis points due to favorable mix from divestiture of the contract manufacturing business and strong incremental performance on organic sales growth. Segment EBITDA for ATS increased 300 basis points driven by robust sales growth and controlled selling and administrative expenses.
Consolidated operating profit increased in 2026 compared to 2025 due to the overall increase in segment EBITDA and lower corporate expenses as well as the absence of severance, acquisition and related inventory step-up amortization costs in 2026.
Page 20
Nordson Corporation
Interest expense and Other expenses
Interest expense for the three months ended January 31, 2026 was $23,131, compared to $26,559 in the comparable period of 2025. The decrease, compared to the prior year period, was primarily due to lower average debt levels. Other income for the three months ended January 31, 2026 was $20,837 compared to $1,526 in the comparable period of 2025. Included in Other income for the three months ended January 31, 2026 was an unrealized gains on minority investment of $22,238, pension and postretirement income of $936 and $2,294 of foreign currency losses. Other income for the three months ended January 31, 2025 included pension and postretirement income of $1,015 and $331 in foreign currency gains.
Income Tax Expense
Income tax expense was $31,119, or 18.9% of pre-tax income, for the three months ended January 31, 2026, as compared to $22,203, or 19.0% of pre-tax income for the three months ended January 31, 2025.
Net Income
Net income was $133,382, or $2.38 per diluted share, for the three months ended January 31, 2026, compared to net income of $94,652, or $1.65 per diluted share, in the same period of 2025. This represented a 40.9 percent increase in net income and a 44.2 percent increase in diluted earnings per share. The increase of $0.73 per diluted share was driven by higher operating profit, lower interest expense, higher other income from the unrealized gain on minority investment and the benefit of share repurchases.
Financial Condition
Liquidity and Capital Resources
Cash and cash equivalents increased $11,950 during the three months ended January 31, 2026. Approximately 74 percent of our consolidated cash and cash equivalents were held at various foreign subsidiaries as of January 31, 2026.
A comparison of cash flow changes for the three months ended January 31, 2026 to the three months ended January 31, 2025 is as follows:
| Three Months Ended | |||||||||||||||||
| January 31, 2026 | January 31, 2025 | Increase (Decrease) | |||||||||||||||
| Net Income and non-cash items | $ | 158,292 | $ | 134,843 | $ | 23,449 | |||||||||||
| Changes in operating assets and liabilities | (17,864) | 24,279 | (42,143) | ||||||||||||||
| Net cash provided by operating activities | 140,428 | 159,122 | (18,694) | ||||||||||||||
| Additions to property, plant and equipment | (17,513) | (21,399) | 3,886 | ||||||||||||||
| Other - net | (158) | 7,123 | (7,281) | ||||||||||||||
| Net cash used in investing activities | (17,671) | (14,276) | (3,395) | ||||||||||||||
| Net (repayment) issuance of long-term debt - net | 2,367 | (22,563) | 24,930 | ||||||||||||||
| Repayment of finance lease obligations | (1,616) | (1,320) | (296) | ||||||||||||||
| Dividends paid | (45,786) | (44,602) | (1,184) | ||||||||||||||
| Issuance of common shares | 18,795 | 1,001 | 17,794 | ||||||||||||||
| Purchase of treasury shares | (86,001) | (60,098) | (25,903) | ||||||||||||||
| Net cash used in financing activities | $ | (112,241) | $ | (127,582) | $ | 15,341 |
The decrease in working capital was principally driven by a decrease in cash provided by accounts receivable collections. During three months ended January 31, 2026, the Company was able to utilize its strong cashflow generation to repurchase $86 million in common shares, pay $46 million in dividends, and fund capital projects to drive organic growth.
We have a $1,200,000 unsecured multi-currency credit facility with a group of banks, maturing in January 2031. At January 31, 2026, we had $400,000 outstanding on the revolving credit facility.
Our operating performance, balance sheet position and financial ratios for the three months ended January 31, 2026 remained strong. We are in compliance with all covenants in the agreements governing our debt as of January 31, 2026. The Company is well-positioned to manage liquidity needs that arise from working capital requirements, capital expenditures, contributions related to pension and postretirement obligations, principal and interest payments on our outstanding debt, dividends, and share repurchases. Our primary sources of capital to meet these needs, as well as other opportunistic investments, are a combination of cash on hand, which was $120,392 as of January 31, 2026, cash provided by operations, which was $140,428 for the three months
Page 21
Nordson Corporation
ended January 31, 2026, and available borrowings under our loan agreements and unused bank lines of credit, which totaled $945,420 as of January 31, 2026. Cash from operations, which when combined with our available borrowing capacity and ready access to capital markets, is expected to be more than adequate to fund our liquidity needs over the twelve months and the foreseeable future thereafter. The Company believes it has the ability to generate and obtain adequate amounts of cash to meet its short-term and long-term needs for cash. However, the impact of changes in trade policies, tariffs, and other import/export regulations of the United States and other nations could negatively impact our cash flow from operations and liquidity in future periods.
Safe Harbor Statements Under the Private Securities Litigation Reform Act of 1995
This Quarterly Report on Form 10-Q, particularly “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains forward-looking statements within the meaning of the Securities Act of 1933, as amended, the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such statements relate to, among other things, income, earnings, cash flows, changes in operations, operating improvements, businesses in which we operate and the United States and global economies. Statements in this annual report that are not historical are hereby identified as “forward-looking statements” and may be indicated by words or phrases such as “anticipates,” “supports,” “plans,” “projects,” “expects,” “believes,” “should,” “would,” “could,” “hope,” “forecast,” “management is of the opinion,” use of the future tense and similar words or phrases. These forward-looking statements reflect management’s current expectations and involve a number of risks and uncertainties. These risks and uncertainties include, but are not limited to, U.S. and international economic and political conditions; financial and market conditions; currency exchange rates and devaluations; possible acquisitions and the Company’s ability to complete and successfully integrate acquisitions; the Company’s ability to successfully divest or dispose of businesses that are deemed not to fit with its strategic plan; the effects of changes in U.S. trade policy and trade agreements, including changes in tariffs by the United States or other nations; the effects of changes in tax law; and the possible effects of events beyond our control, such as political unrest, including the conflicts in Europe and the Middle East, acts of terror, natural disasters and pandemics.
In light of these risks and uncertainties, actual events and results may vary significantly from those included in or contemplated or implied by such forward-looking statements. Readers are cautioned not to place undue reliance on such forward-looking statements. These forward-looking statements speak only as of the date made. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Factors that could cause our actual results to differ materially from the expected results are discussed in Part I, Item 1A, Risk Factors in our 2025 Form 10-K and Part II, Item 1A, Risk Factors in the Quarterly Report on Form 10-Q.
Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Information regarding our financial instruments that are sensitive to changes in interest rates and foreign currency exchange rates was disclosed under Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk” in our 2025 Form 10-K. The information disclosed has not changed materially in the interim period since then.
Item 4. CONTROLS AND PROCEDURES
Our management with the participation of the principal executive officer (president and chief executive officer) and principal financial officer (executive vice president and chief financial officer) has reviewed and evaluated our disclosure controls and procedures (as defined in the Exchange Act Rule 13a-15(e)) as of January 31, 2026. Based on that evaluation, our management, including the principal executive and financial officers, has concluded that our disclosure controls and procedures were effective as of January 31, 2026 in ensuring that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms and is accumulated and communicated to management, including the principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
There were no changes in our internal control over financial reporting that occurred during the three months ended January 31, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Page 22
Nordson Corporation
Part II – OTHER INFORMATION
Item 1. LEGAL PROCEEDINGS
See our Contingencies Note to the condensed consolidated financial statements for a discussion of our contingencies and legal matters.
Item 1A. RISK FACTORS
In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the risk factors disclosed in “Item 1A. Risk Factors” of our 2025 Form 10-K. There have been no material changes to the risk factors described in the 2025 Form 10-K.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
The following table summarizes common shares repurchased by the Company during the three months ended January 31, 2026:
| (In whole shares) | Total Number of Shares Repurchased (1) | Average Price Paid per Share | Total Number of Shares Repurchased as Part of Publicly Announced Plans or Programs (2) | Maximum Value of Shares that May Yet Be Purchased Under the Plans or Programs (2) | ||||||||||||||||||||||
| November 1, 2025 to November 30, 2025 | 115,699 | $ | 232.49 | 115,653 | $ | 697,345 | ||||||||||||||||||||
| December 1, 2025 to December 31, 2025 | 147,020 | $ | 238.61 | 138,204 | $ | 664,348 | ||||||||||||||||||||
| January 1, 2026 to January 31, 2026 | 87,883 | $ | 258.95 | 87,089 | $ | 641,802 | ||||||||||||||||||||
| Total | 350,602 | $ | 241.69 | 340,946 | $ | 641,802 |
(1) Includes shares tendered for taxes related to stock option exercises and vesting of restricted stock.
(2) On August 20, 2025, the Company announced that its board of directors authorized the repurchase of up to an additional $500,000 of the Company's common shares. As of January 31, 2026, approximately $641,802 remained available for share repurchases under existing share repurchase authorizations. Uses for repurchased shares include the funding of benefit programs including stock options and restricted stock. Shares purchased are treated as treasury shares until used for such purposes. The repurchase program will be funded using cash from operations and proceeds from borrowings under our credit facilities. The repurchase program does not have an expiration date.
Page 23
Nordson Corporation
Item 5. OTHER INFORMATION
During the quarter ended January 31, 2026, no director or officer (as defined in Rule 16a-1(f) promulgated under the Exchange Act) of the Company adopted or terminated any “Rule 10b5-1 trading arrangement” or any “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K, except as described in the table below:
| Trading Arrangement | ||||||||||||||||||||
| Action | Action Date | Rule 10b5-11 | Non-Rule 10b5-12 | Total Shares to be Sold | Expiration Date | |||||||||||||||
| Sundaram Nagarajan Chief Executive Officer | Terminated3 | 1/12/2026 | x | Up to 41,8004 shares | 7/10/2026 | |||||||||||||||
| Sundaram Nagarajan Chief Executive Officer | Adopted | 1/12/2026 | x | Up to 41,8005 shares | 12/31/2026 | |||||||||||||||
| Joseph P. Kelley Executive Vice President | Adopted | 1/16/2026 | x | Up to 2,310 shares | 1/15/2027 | |||||||||||||||
| 1 Intended to satisfy the affirmative defense of Rule 10b5-1(c) | ||||||||||||||||||||
| 2 Not intended to satisfy the affirmative defense of Rule 10b5-1(c) | ||||||||||||||||||||
| 3 The 10b5-1 Plan originally adopted by Mr. Nagarajan on April 3, 2025, was terminated in connection with the adoption of a new Rule 10b5-1 Plan on January 12, 2026. | ||||||||||||||||||||
| 4 The Company’s prior disclosure in its Quarterly Report on Form 10‑Q for the quarterly period ended April 30, 2025 incorrectly stated that terminated Rule 10b5-1 Plan covered 40,000 shares. The correct number of shares covered under the terminated Rule 10b5-1 Plan was 41,800 shares. | ||||||||||||||||||||
| 5 Mr. Nagarajan's Rule 10b5-1 Plan provides for the potential sale of up to 41,800 shares of the Company’s common stock, all of which Mr. Nagarajan may acquire upon the exercise of outstanding stock options. |
| ITEM 6. | EXHIBITS |
| 10.1 | Amended and Restated Credit Agreement, dated as of January 30, 2026, by and among Nordson Corporation, as Borrower, Nordson Engineering GmbH, as German Borrower, Wells Fargo Bank, National Association, as Administrative Agent, and various financial institutions named therein as lenders (incorporated herein by reference to Exhibit 10.1 to Registrant's Current Report on Form 8-K dated February 2, 2026). | ||||
| 31.1 | Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934 by the Chief Executive Officer, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 31.2 | Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934 by the Chief Financial Officer, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 32.1 | Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith). | ||||
| 32.2 | Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith). | ||||
| 101 | The following financial information from Nordson Corporation’s Quarterly Report on Form 10-Q for the three months ended January 31, 2026 formatted in inline Extensible Business Reporting Language (iXBRL): (i) the Condensed Consolidated Statements of Income for the three months ended January 31, 2026 and 2025, (ii) the Consolidated Statements of Comprehensive Income for the three months ended January 31, 2026 and 2025, (iii) the Consolidated Balance Sheets at January 31, 2026 and October 31, 2025, (iv) the Consolidated Statements of Shareholders’ Equity for the three months ended January 31, 2026 and 2025, (v) the Condensed Consolidated Statements of Cash Flows for the three months ended January 31, 2026 and 2025, and (vi) the Notes to Condensed Consolidated Financial Statements. | ||||
| 104 | The cover page from Nordson Corporation’s Quarterly Report on Form 10-Q for the quarter ended January 31, 2026, formatted in inline Extensible Business Reporting Language (iXBRL) (included in Exhibit 101). |
Page 24
Nordson Corporation
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| Date: February 19, 2026 | Nordson Corporation | ||||
| /s/ Joseph Rutledge | |||||
| Joseph Rutledge | |||||
| Chief Accounting Officer |
Page 25